Using a glowing dye to help see pancreatic cancer during surgery
Part of Cancer clinical trials.
This trial tests whether a special dye (SGM-101) can help surgeons see remaining cancer cells during surgery for pancreatic cancer that has been treated before surgery. It may lead to more complete removal of the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been treated with chemotherapy or radiation for pancreatic cancer before surgery
- Your pancreatic cancer is considered borderline resectable or locally advanced
- You are scheduled to have surgery to remove the tumor
- You are 18 years or older
- You can communicate in Dutch or English
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a targeted antibody with a fluorescent dye can help surgeons see and remove pancreatic cancer during planned surgery. It’s an early-phase study, so the main goal is to see if the approach is safe and useful around the time of the operation.
This study looks at specific body chemistry pathways in pancreatic cancer tissue to better understand what may help treatment work. If you are having pancreatic surgery, the researchers will take extra small tissue samples during the operation to study tumor and normal tissue.
This trial compares standard laparoscopic surgery to surgery using a green dye that helps the surgeon see the pancreas more clearly. It may help patients needing removal of tumors in the body or tail of the pancreas.
This trial tests a drug called pafolacianine (CYTALUX) that makes cancer cells glow during surgery. It may help doctors see and remove more cancer from the stomach, esophagus, or appendix. You take the drug before surgery, and a special camera shows the glowing cancer.
This trial tests a new treatment, PTM-101, placed during a laparoscopy procedure for people with pancreatic cancer that can be removed with surgery. It aims to see if adding this treatment before standard chemotherapy helps improve outcomes.
This trial tests an experimental drug called CEB-01 in people with pancreatic cancer that can be surgically removed. It aims to see if adding this drug to surgery improves outcomes.
Hear when a new Pancreas Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.